Lucid Diagnostics LUCD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.26M-16.5% | $1.5M+24.2% | $1.21M+4.1% | $1.16M+40.5% | $828K-30.8% | ||
| $1.63M— | —— | —— | —— | $1.55M-12.6% | ||
| $1.21M-30.0% | $1.72M+35.5% | $1.27M+1.4% | $1.26M-12.1% | $1.43M-1.7% | ||
| $5M-6.4% | $5.34M+24.5% | $4.29M+7.1% | $4.01M-1.5% | $4.07M+1.6% | ||
| $5.43M-16.2% | $6.48M+15.7% | $5.61M-0.2% | $5.62M-8.8% | $6.16M+5.1% | ||
| $13.37M— | —— | —— | —— | $13.32M+5.7% | ||
| -$12.11M+13.5% | -$14.01M-19.2% | -$11.76M-3.3% | -$11.38M+8.8% | -$12.49M-0.9% | ||
| -964.5%-32.9pp | -931.6%+39.4pp | -971%+7.8pp | -978.8%+529pp | -1,508.1%-474pp | ||
| $6K0.0% | $6K+200% | $2K-66.7% | $6K-33.3% | $9K+28.6% | ||
| -$1.8M+20.4% | -$2.26M-266% | $1.36M-80.4% | $6.95M+148% | -$14.42M-1,829% | ||
| -$13.91M+14.5% | -$16.27M-56.4% | -$10.4M-134% | -$4.44M+83.5% | -$26.91M-133% | ||
| $0— | —— | —— | —— | $0— | ||
| -$13.91M+14.5% | -$16.27M-56.4% | -$10.4M-134% | -$4.44M+83.5% | -$26.91M-133% | ||
| -1,107.4%-25.9pp | -1,081.5%-223pp | -858.5%-477pp | -381.7%+2,868pp | -3,249.8%-2,286pp | ||
| -$11.89M+13.8% | -$13.8M-19.6% | -$11.54M-3.4% | -$11.16M+9.0% | -$12.27M-0.9% | ||
| -946.8%-29.1pp | -917.7%+35.2pp | -952.8%+6.9pp | -959.8%+522pp | -1,481.4%-466pp | ||
| -$12.11M+13.5% | -$14.01M-19.2% | -$11.76M-3.3% | -$11.38M+8.8% | -$12.49M-0.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lucid Diagnostics's revenue?
- Lucid Diagnostics (LUCD) generated $5.1M in revenue over the trailing twelve months, up 23.0% year over year.
- Is Lucid Diagnostics profitable?
- Lucid Diagnostics is not currently profitable: it reported a net loss of $45.0M over the trailing twelve months, a -876.7% net margin.
- What are Lucid Diagnostics's profit margins?
- Gross margin is -66.8% and operating margin is -959.6%, with a -876.7% net margin.
- Where does Lucid Diagnostics's income statement data come from?
- Every line is extracted from Lucid Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
